Prometheus Biosciences, Inc.
RXDXNASDAQHealthcare
$199.92
+$0.18(+0.09%)
Market Cap$9.6B
P/E Ratio—
52W High$199.96
52W Low$23.27
Prometheus Biosciences, Inc. (RXDX) Stock Splits
No forward or reverse splits on record since IPO — details below.
FMP · RXDX · as of Jun 15, 2023
Key split metrics
—
Prometheus Biosciences, Inc. (RXDX) has been publicly traded since Mar 12, 2021 with no forward or reverse splits on record.
About stock split history
Prometheus Biosciences, Inc. (RXDX) has never undergone a stock split since going public.
Frequently asked questions
Prometheus Biosciences, Inc. (RXDX) has never split its stock since going public.
RXDX stock split historyhas RXDX ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.